Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study by Garassino, Marina Chiara, Kim, Joo-Hang, Corral Jaime, Jesus, Powderly, John, Bidoli, Paolo, Wheatley-Price, Paul, Park, Keunchil, Wadsworth, Catherine, Dennis, Phillip A, Rizvi, Naiyer A, Paz-Ares Rodriguez, Luis, Novello, Silvia, Hiret, Sandrine, Schmid, Peter, Laack, Eckart, Califano, Raffaele, Vicente Baz, David, Berghmans, Thierry, Kim, Dong-Wan, Surmont, Veerle, Reck, Martin, Han, Ji-Youn, Holgado Martin, Esther, Chella, Antonio, Chopra, Akhil, Robinet, Gilles, Soto Parra, Hector, Thomas, Michael, Katakami, Nobuyuki, Su, Wu-Chou, Kim, Young-Chul, Lee, Jong-Seok, Saka, Hideo, Milella, Michele, Ramos Garcia, Inmaculada, Sibille, Anne, Atagi, Shinji, Spaeth-Schwalbe, Ernst, Nishio, Makoto, Imamura, Fumio, Derijcke, Sofie, Maeda, Tadashi, Zylla, Dylan, Santoro, Armando, Uy, Ma. Noemi, Lucien Geater, Sarayut, Kowalski, Dariusz, Chen, Yuh-Min, Spigel, David, Chewaskulyong, Busyamas, Garcia Gomez, Ramon, Alvarez Alvarez, Rosa, Yang, Chih-Hsin, Denis, Fabrice, Sakai, Hiroshi, Canon, Jean-Luc, Scholz, Christian, Kemmotsu, Hirotsugu, Azuma, Koichi, Feld, Ronald, Jassem, Jacek, Kubota, Kaoru, Waterhouse, David, Coudert, Bruno, Mark, Zsuzsanna, Chang, Gee-Chen, Herzmann, Christian, Chaudhry, Arvind, Giridharan, Selvaraj, Hesketh, Paul, Boccia, Ralph, Iannotti, Nichola, Haigentz, Missak, Reynolds, John, Nakagawa, Kazuhiko, Sugawara, Shunichi, Tan, Eng Huat, Takeda, Koji, Mohn-Staudner, Andrea, Panwalkar, Amit, Daniel, Davey, Kobayashi, Kunihiko, Ladrera, Guia Elena Imelda, Coupkova, Helena, Havel, Libor, Singh, Joginder, Murakami, Shuji, Anderson, Ian, Iqbal, Mussawar, Torri, Vamsee, Juhasz, Erzsebet, Koubkova, Leona, Levy, Benjamin, Page, Ray, Crinò, Lucio, Einspahr, David, Hagenstad, Christopher, Juat, Necy, Overton, Lindsay, Szalai, Zsuzsanna

Get full text

Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory lymphoma: a prospective multi-center phase II study by the Puget... by Gopal, Ajay K., Press, Oliver W., Shustov, Andrei R., Petersdorf, Stephen H., Gooley, Ted A., Daniels, Jasmine T., Garrison, Mitchell A., Gjerset, George F., Lonergan, Matthew, Murphy, Anne E., Smith, Julie C., Pagel, John M.

Get full text

Phase I and Pharmacokinetic Study of Tasidotin Hydrochloride (ILX651), a Third-Generation Dolastatin-15 Analogue, Administered Weekly for 3 Weeks Every 28 Days in Patients with Adv... by MITA, Alain C, HAMMOND, Lisa A, WEITMAN, Steve, ROWINSKY, Eric K, BONATE, Peter L, WEISS, Geoffrey, MCCREERY, Heather, SYED, Samira, GARRISON, Mitchell, CHU, Quincy S. C, DEBONO, Johann S, JONES, Christopher B

Get full text

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, ph... by Richardson, Paul G, Beksac, Meral, Liberati, Anna Marina, Galli, Monica, Lindsay, Jindriska, White, Darrell, Facon, Thierry, San Miguel, Jesus, Sunami, Kazutaka, O'Gorman, Peter, Sonneveld, Pieter, Robak, Pawel, Schey, Steve, Yu, Xin, Bensmaine, Amine, Zaki, Mohamed, Abildgaard, Niels, Adler, Howard, Altuntas, Fevzi, Arce-Lara, Carlos, Aydin, Yildiz, Basu, Supratik, Battini, Ramakrishna, Beeker, Thaddeus, Ben-Yehuda, Dina, Boccia, Ralph, Cavo, Michele, Chantry, Andrew, Chaudhry, Arvind, Corso, Alessandro, De Arriba, Felipe, Delimpasi, Sosana, Desjardins, Pierre, Dhakal, Binod, Di Bartolomeo, Paolo, Dürig, Jan, Engelhardt, Monika, Esteves, Graca, Flogegard, Max, Gabrail, Nashat, Gamberi, Barbara, Garrison, Mitchell, Gisslinger, Heinz, Goldschmidt, Hartmut, Gressot, Laurent, Grosicki, Sebastian, Hanna, Wahid, Henriques Bernardo, Maria Manuela, Hermann, Robert, Holden, Viran, Huben, Marianne, Janakiram, Murali, Jenner, Matthew, João, Cristina, Jurcyszyn, Artur, Kalayoğlu Beşişik, Sevgi, Kambhampati, Suman, Karadoğan, Ihsan, Khojasteh, Ali, Kirkel, Dean, Komarnicki, Mieczyslaw, Lauri, Birgitta, Leleu, Xavier, Matsue, Kosei, Mendeleeva, Larisa, Miller, Carole, Mohrbacher, Ann, Müldür, Ercan, Naassan, Anthony, Nahi, Hareth, Nair, Rajesh, O'Dwyer, Mike, Openshaw, Thomas, O'Rourke, Timothy, Osswald, Michael, Overton, Lindsay, Pavic, Michel, Pierola, Ana Alfonso, Rabin, Neil, Ramasamy, Karthik, Rambaldi, Alessandro, Rodriguez, Paula, Röllig, Christoph, Rosenblatt, Jacalyn, Rosenbluth, Jonathan, Salomo, Morten, Samoylova, Olga, Sastre Moral, Jose, Shafeek, Salim, Shinagawa, Atsushi, Sleckman, Bethany, Smith, Clay, Suzuki, Kenshi, Takezako, Naoki, Teke, Hava Üsküdar, Vapaatalo, Mirja, Vassilopoulos, George, Verma, Amit, Wang, Xiang Sean, Yağci, Munci

Get full text

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial by Wenham, Robert M, Pickett, Cheryl A, Park, Sang Yoon, Makarova, Yulia, Krikunova, Ludmila, Bae, Duk-Soo, Zamagni, Claudio, Tognon, Germana, Ortega, Eugenia, Green, Andrew, Burger, Robert, Sanchez, Andres Redondo, Peen, Ulla, Kamelle, Scott, Carney, Michael, Forget, Frédéric, Bentley, James, Sehouli, Jalid, Kato, Hidenori, Shahin, Mark, Bhoola, Snehalkumar, Anderson, Daniel, Pelgrims, Joseph (Gino), Hansen, Vincent, Van den Bulck, Heidi, Yokota, Harushige, Friedman, Richard, Covens, Allan, Hilpert, Felix, Savarese, Antonella, Pignata, Sandro, Teneriello, Michael, Lentz, Samuel, Mannel, Robert, Lim, Peter, Zorr, Andreas, Karck, Ulrich, Aoki, Daisuke, Hirashima, Yasuyuki, Boere, Ingrid, Braly, Patricia, Schilder, Jeanne, Secord, Angeles, Rojas-Espaillat, Luis, Schauer, Christian, Joosens, Eric, Burges, Alexander, Park-Simon, Tjoung-Won, Alabiso, Oscar, Sawasaki, Takashi, Ibañez, Ana Herrero, Spillman, Monique, Moore, David, Verhoeven, Didier, Schnappauf, Benjamin, Schmalzrie, Hannah, Kalofonos, Haralambos, Diaz, Cristina Caballero, Polo, Susana Hernando, Garrison, Mitchell, Basil, Jack, Cosin, Jonathan, Wade III, James, Buekers, Thomas, DAndre, Stacy, Bakkum-Gamez, Jamie, Van Le, Linda, Puls, Larry, Michelson, Elizabeth Dickson, Kerger, Joseph, Heubner, Martin, Lordick, Florian, Villanueva, William Orlando Brito, Kessels, Lonneke, Fabregat, Miguel Beltran, Kumar, Pallavi, Karimi, Misagh, Edraki, Babak, Morris, Robert, Method, Michael, Drake, Janet, Wadsworth, Troy, Hurteau, Jean, Malad, Salman, Robinson-Bennett, Bernice, Davidson, Susan, Gaur, Rakesh, Krasner, Carolyn, Ueland, Frederick, Talmage, Lance, Sutton, Gregory, Osborne, Janet, Williams, James, Fleming, Nicole, Herzog, Thomas, Leitao, Mario, Mendez, Luis, Patel, Dhimant, Spitzer, Gary, Miller, Brigitte

Get full text

Impact of Socioeconomic Factors on Access to and Outcomes of Allogeneic Hematopoietic Cell Transplantation (allo-HCT) for Acute Myeloid Leukemia (AML): A Multi-Center Observational... by Wuliji, Natalie, Gooley, Ted, Jones, Salene, Gerds, Aaron T., Medeiros, Bruno, Shami, Paul J., Galvin, John, Adekola, Kehinde, Luger, Selina, Baer, Maria R., Rizzieri, David A., Wildes, Tanya M., Wang, Eunice S., Sekeres, Mikkael A., Mukherjee, Sudipto, Smith, Julie C., Garrison, Mitchell A., Kojouri, Kiarash, Appelbaum, Jacob S., Percival, Mary-Elizabeth M., Sandmaier, Brenda M., Appelbaum, Frederick R., Sorror, Mohamed

Get full text

Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia by Sorror, Mohamed L., Storer, Barry E., Fathi, Amir T., Brunner, Andrew, Gerds, Aaron T., Sekeres, Mikkael A., Mukherjee, Sudipto, Medeiros, Bruno C., Wang, Eunice S., Vachhani, Pankit, Shami, Paul J., Peña, Esteban, Elsawy, Mahmoud, Adekola, Kehinde, Luger, Selina, Baer, Maria R., Rizzieri, David, Wildes, Tanya M., Koprivnikar, Jamie, Smith, Julie, Garrison, Mitchell, Kojouri, Kiarash, Leisenring, Wendy, Onstad, Lynn, Nyland, Jennifer E., Becker, Pamela S., McCune, Jeannine S., Lee, Stephanie J., Sandmaier, Brenda M., Appelbaum, Frederick R., Estey, Elihu H.

Get full text

An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML by Sorror, Mohamed L., Gooley, Ted A., Storer, Barry E., Gerds, Aaron T., Sekeres, Mikkael A., Medeiros, Bruno C., Wang, Eunice S., Shami, Paul J., Adekola, Kehinde, Luger, Selina, Baer, Maria R., Rizzieri, David A., Wildes, Tanya M., Koprivnikar, Jamie, Smith, Julie, Garrison, Mitchell, Kojouri, Kiarash, Schuler, Tammy A., Leisenring, Wendy M., Onstad, Lynn E., Becker, Pamela S., McCune, Jeannine S., Lee, Stephanie J., Sandmaier, Brenda M., Appelbaum, Frederick R., Estey, Elihu H.

Get full text

Combined Targeted Therapies for First-line Treatment of Metastatic Triple Negative Breast Cancer—A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance T... by Symonds, Lynn, Linden, Hannah, Gadi, Vijayakrishna, Korde, Larissa, Rodler, Eve, Gralow, Julie, Redman, Mary, Baker, Kelsey, Wu, Quan (Vicky), Jenkins, Isaac, Kurland, Brenda, Garrison, Mitchell, Smith, Julie, Anderson, Jeanne, Van Haelst, Carol, Specht, Jennifer

Get full text

Novel Data Analytics Identify Predictors of Quality-of-Life Trajectories in Patients with AML or High-Risk Myeloid Neoplasms by Gauthier, Jordan, Furtuna, Bianca, Mangiavacchi, Jacopo, Gholami, Shahrzad, Lavista Ferres, Juan, Dodhia, Rahul, Fathi, Amir T., Brunner, Andrew M., Gerds, Aaron T., Sekeres, Mikkael A., Medeiros, Bruno C., Wang, Eunice S., Shami, Paul J, Adekola, Kehinde, Luger, Selina M., Baer, Maria R., Rizzieri, David A, Wildes, Tanya, Koprivnikar, Jamie L., Smith, Julie, Garrison, Mitchell A., Kojouri, Kiarash, Appelbaum, Frederick R., Percival, Mary-Elizabeth M., Lee, Stephanie J., Sorror, Mohamed L.

Get full text

A Phase I and Pharmocokinetic Study of Exatecan Mesylate Administered as a Protracted 21-Day Infusion in Patients with Advanced Solid Malignancies by GARRISON, Mitchell A, HAMMOND, Lisa A, DE JAGER, Robert L, ROWINSKY, Eric K, GEYER, Charles E, SCHWARTZ, Garry, TOLCHER, Anthony W, SMETZER, Leslie, FIGUEROA, Jose A, DUCHARME, Murray, COYLE, John, TAKIMOTO, Chris H

Get full text

Barriers to Receiving Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Insights From a Large-Scale Multicenter Observational Study by Wuliji, Natalie, Gooley, Ted, Gerds, Aaron, Mukherjee, Sudipto, Medeiros, Bruno, Shami, Paul, Galvin, John, Adekola, Kehinde, Luger, Selina, Baer, Maria, Rizzieri, David, Wildes, Tanya, Wang, Eunice, Sekeres, Mikkael, Smith, Julie, Garrison, Mitchell, Kojouri, Kiarash, Percival, Mary‐Elizabeth, Sandmaier, Brenda, Appelbaum, Frederick, Sorror, Mohamed

Get full text

AML-591 Barriers to Receiving Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Insights From a Large-Scale Multicenter Observational Study by Wuliji, Natalie, Gooley, Ted, Gerds, Aaron, Mukherjee, Sudipto, Medeiros, Bruno, Shami, Paul, Galvin, John, Adekola, Kehinde, Luger, Selina, Baer, Maria, Rizzieri, David, Wildes, Tanya, Wang, Eunice, Sekeres, Mikkael, Smith, Julie, Garrison, Mitchell, Kojouri, Kiarash, Percival, Mary-Elizabeth, Sandmaier, Brenda, Appelbaum, Frederick, Sorror, Mohamed

Get full text

Limitations to Receiving Allogeneic Hematopoietic Cell Transplantation for Treatment of Acute Myeloid Leukemia: A Large Multi-Center Prospective Longitudinal Observational Study by Sorror, Mohamed L., Storer, Barry E., Gerds, Aaron T., Medeiros, Bruno C., Shami, Paul J, Galvin, John P., Adekola, Kehinde U., Luger, Selina, Baer, Maria R., Rizzieri, David A., Wildes, Tanya M., Wang, Eunice S., Faderl, Stefan, Koprivnikar, Jamie L., Sekeres, Mikkael A., Mukherjee, Sudipto, Smith, Julie, Garrison, Mitchell, Kojouri, Kiarash, Nyland, Jennifer E., Moore, Rachelle R., Fleuret, Sophie L., Lynch, Ylinne, Becker, Pamela S., Percival, Mary-Elizabeth M., Sandmaier, Brenda M., Appelbaum, Frederick R., Estey, Elihu H.

Get full text

Survival Differences Among Patients (pts) with Acute Myeloid Leukemia (AML) Treated with Allogeneic Hematopoietic Cell Transplantation (HCT) Versus Non-HCT Therapies: A Large Real-... by Sorror, Mohamed L., Storer, Barry E., Gerds, Aaron T., Medeiros, Bruno C., Shami, Paul J, Galvin, John P., Adekola, Kehinde U., Luger, Selina, Baer, Maria R., Rizzieri, David A., Wildes, Tanya M., Wang, Eunice S., Faderl, Stefan, Koprivnikar, Jamie L., Sekeres, Mikkael A., Mukherjee, Sudipto, Smith, Julie, Garrison, Mitchell, Kojouri, Kiarash, Nyland, Jennifer E., Moore, Rachelle R., Fleuret, Sophie L., Lynch, Ylinne, Becker, Pamela S., Percival, Mary-Elizabeth M., Sandmaier, Brenda M., Appelbaum, Frederick R., Estey, Elihu H.

Get full text

AML-145: Multicenter 11-Year Experience of Outcomes After Intensive Versus Less-Intensive Therapy for Patients with Acute Myeloid Leukemia: Focus on Older and Medically Infirm Pati... by Sorror, Mohamed, Storer, Barry, Fathi, Amir, Brunner, Andrew, Gerds, Aaron, Sekeres, Mikkael, Medeiros, Bruno, Wang, Eunice, Shami, Paul, Adekola, Kehinde, Luger, Selina, Baer, Maria, Rizzieri, David, Wildes, Tanya, Koprivnikar, Jamie, Garrison, Mitchell, Kojouri, Kiarash, Schuler, Tammy, Leisinring, Wendy, Onstad, Lynn, Becker, Pamela, McCune, Jeannine, Lee, Stephanie, Sandmaier, Brenda, Appelbaum, Frederick, Estey, Elihu

Get full text

Multi-Site 11-Year Experience of Less-Intensive versus Intensive Therapies in Acute Myeloid Leukemia by Sorror, Mohamed Lotfy, Storer, Barry E, Fathi, Amir T, Brunner, Andrew M, Gerds, Aaron T, Sekeres, Mikkael A, Mukherjee, Sudipto, Medeiros, Bruno C, Wang, Eunice S, Vachhani, Pankit, Shami, Paul J, Peña, Esteban, Elsawy, Mahmoud, Adekola, Kehinde U A, Luger, Selina, Baer, Maria R, Rizzieri, David, Wildes, Tanya, Koprivnikar, Jamie, Smith, Julie, Garrison, Mitchell, Kojouri, Kiarash, Leisenring, Wendy M, Onstad, Lynn, Nyland, Jennifer E, Becker, Pamela S, McCune, Jeannine S, Lee, Stephanie J, Sandmaier, Brenda M, Appelbaum, Frederick, Estey, Elihu H

Get full text

Cantuzumab mertansine in a three-times a week schedule: a phase I and pharmacokinetic study by Rodon, Jordi, Garrison, Mitchell, Hammond, Lisa A., de Bono, Johann, Smith, Lon, Forero, Leonardo, Hao, Desirée, Takimoto, Chris, Lambert, John M., Pandite, Lini, Howard, Maria, Xie, Hongsheng, Tolcher, Anthony W.

Get full text

A Prospective Multicenter Phase II Study by the Puget Sound Oncology Consortium (PSOC) of Gemcitabine (G), Carboplatin (C), Dexamethasone (D), and Rituximab (R) in Patients with Re... by Gopal, Aj ay K, Press, Oliver W., Shustov, Andrei, Petersdorf, Stephen, Gooley, Ted, Daniels, Jasmine T., Garrison, Mitchell, Gjerset, George, Lonergan, Matthew, Murphy, Anne, Smith, Julie, Pagel, John M.

Get full text

Limitations to Receiving Allogeneic Hematopoietic Cell Transplantation for Treatment of Acute Myeloid Leukemia: A Large Multi-Center Prospective Longitudinal Observational Study by Sorror, Mohamed L., Storer, Barry E., Gerds, Aaron T., Medeiros, Bruno C, Shami, Paul J., Galvin, John P., Adekola, Kehinde U., Luger, Selina M., Baer, Maria R., Rizzieri, David A, Wildes, Tanya M., Wang, Eunice S., Faderl, Stefan, Koprivnikar, Jamie L., Sekeres, Mikkael A., Mukherjee, Sudipto, Smith, Julie, Garrison, Mitchell, Kojouri, Kiarash, Nyland, Jennifer E., Moore, Rachelle R., Fleuret, Sophie L., Lynch, Ylinne, Becker, Pamela S., Percival, Mary-Elizabeth M., Sandmaier, Brenda M., Appelbaum, Frederick R., Estey, Elihu H.

Get full text